News

Jianpu Technology Reports Impressive Financial Growth in 2025

Jianpu Technology Reports Impressive Financial Growth in 2025

Key Highlights of Jianpu Technology's Financial Performance

Jianpu Technology Inc. (OTCQB: AIJTY), a recognized leader in open financial technology, has reported remarkable growth in its financial results for the first half of 2025. This growth underscores the company’s capacity to innovate and adapt within the competitive financial technology landscape.

Growth in Total Revenues

The company's total revenues surged by 29.9%, achieving RMB 557.6 million (approximately US$77.8 million) in the first half of 2025. This marks a significant increase from RMB 429.2 million during the same period in the previous year, demonstrating the effectiveness of Jianpu's strategic initiatives and the rising demand for its services.

Revenue Breakdowns: Strong Performance Across Segments

Recommendation Services

Jianpu's recommendation services experienced a stellar growth of 52.7%, resulting in revenues of RMB 442.4 million (about US$61.8 million). This growth was largely driven by heightened application volumes for loans, even as the company phased out its credit card recommendation services.

Digital Intelligence as a Service

In another positive development, revenues from digital intelligence as a service increased by 38.3% to RMB 51.6 million (around US$7.2 million). The primary driver for this growth was an expanded customer base, which has increasingly sought out innovative digital solutions.

Marketing and Other Services

However, revenues from marketing and other services saw a decline of 37.7%, falling to RMB 63.7 million (approximately US$8.9 million). This decline is attributed to the deconsolidation of Anguo and the board's decision to wind down certain non-core business activities in April 2025.

Expenses and Profitability Metrics

While revenues were on the rise, Jianpu also experienced an increase in its costs. The cost of promotion and acquisition rose by 37.0% to RMB 338.5 million (approximately US$47.2 million), reflecting the growing investment in its successful loan recommendation services.

Operational costs rose 41.3% to RMB 39.7 million (about US$5.5 million). This increase was primarily due to higher data acquisition costs, complementing the growth in digital intelligence revenues.

Net Income Growth

In terms of profitability, Jianpu reported a staggering 216.5% increase in operating income, which reached RMB 26.9 million (approximately US$3.8 million). The operating margin improved to 4.8% for this period, up from 2.0% in the previous year, primarily driven by ongoing business optimization efforts.

The net income during the first half of 2025 settled at RMB 19.1 million (around US$2.7 million), although this reflected a decrease from RMB 28.9 million in 2024. The decrease in net income margin corresponds to the transformations the company is navigating during dynamic market conditions.

Strategic Directions for the Future

As Jianpu Technology expands into the FinTech+ ecosystem and broadens its international reach, it remains committed to fostering innovation in financial technology and digital transformation. The management is focused on integrating advanced technology while ensuring customer satisfaction and improving overall service delivery.

Conclusion

Jianpu Technology Inc.'s recent financial performance illustrates both resilience and growth in a competitive market. With its focus on innovation and comprehensive financial services, the company is set to continue leading in the financial technology sector.

Frequently Asked Questions

What was Jianpu Technology's revenue growth in the first half of 2025?

The company reported a total revenue increase of 29.9% compared to the previous year.

Which revenue segment showed the most significant growth?

Revenue from recommendation services increased by 52.7%, driven by loan applications.

What are the main drivers of Jianpu’s cost increases?

The elevated costs can largely be attributed to increased spending on promotion and acquisition in support of growing loan services.

How did net income change for Jianpu in this period?

Net income fell to RMB 19.1 million from RMB 28.9 million, reflecting changes in market conditions.

What is the strategic outlook for Jianpu Technology going forward?

Jianpu plans to expand its FinTech+ ecosystem and enhance its international presence while continuing to innovate in financial services.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 16

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 25

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 24

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 22

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 14

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 19

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 20

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading

Top 5 Most Recently Viewed Articles

Wingderm USA Expands Its Footprint at 2025 Aesthetic Show

Updated Category News Views 187

Wingderm USA Takes Center Stage at The Aesthetic Show 2025 Wingderm®, an innovative leader in energy-based medical aesthetic technologies, made a significant impact at The Aesthetic Show (TAS) 2025. This event was a pivotal moment in strengthening Wingderm’s position within the U.S. medical aesthetic market. It was held at a renowned venue and brought together medical...

Continue Reading
INVO Bioscience's Strategic Cash Advance Enhances Financial Stability

Updated Category News Views 259

INVO Bioscience Secures Essential Funding INVO Bioscience, Inc. (NASDAQ:INVO), a prominent player in the medical device sector, has recently embarked on a significant financial maneuver to enhance its operational stability. By entering into a Merchant Cash Advance agreement, the company has obtained $265,000, aiming to bolster its working capital and support various...

Continue Reading
FibroGen Secures $160 Million from Sale to AstraZeneca

Updated Category News Views 120

FibroGen Triumphs with Strategic Sale of China Operations FibroGen, Inc. (NASDAQ: FGEN) is making waves in the biopharmaceutical industry with the recent announcement of its agreement to sell its China subsidiary to AstraZeneca for approximately $160 million. This important financial maneuver not only bolsters FibroGen's financial stability but also positions the company...

Continue Reading
Enzoic Teams Up with CIS CyberMarket for Cybersecurity

Updated Category News Views 76

Enzoic Partners with CIS CyberMarket to Strengthen Cybersecurity Enzoic is excited to announce a strategic partnership with CIS CyberMarket, a program designed to enhance the procurement of cybersecurity solutions for various U.S. government entities, nonprofits, and educational institutions. This collaboration aims to provide those organizations with effective,...

Continue Reading
Fosun's Strategic Sale of German Bank Gathers EUR670 Million

Updated Category News Views 589

Fosun International Completes Strategic Sale of HAL Fosun International Limited has successfully finalized the sale of 99.743% of shares in Hauck Aufhäuser Lampe Privatbank AG (HAL), bringing in EUR670 million. This strategic transaction is a significant part of Fosun's ongoing initiatives to optimize its portfolio and focus on core growth sectors. Transforming Private...

Continue Reading